Sickle cell anemia is caused by a mutation in the gene that tells your body to make hemoglobin — the red, iron-rich compound that gives blood its red color. Hemoglobin allows red blood cells to carry oxygen from your lungs to all parts of your body. In sickle cell anemia, the abnormal hemoglobin causes red blood cells to become rigid, sticky and misshapen.
The sickle cell gene is passed from generation to generation in a pattern of inheritance called autosomal recessive inheritance. This means that both the mother and the father must pass on the defective form of the gene for a child to be affected.
If only one parent passes the sickle cell gene to the child, that child will have the sickle cell trait. With one normal hemoglobin gene and one defective form of the gene, people with the sickle cell trait make both normal hemoglobin and sickle cell hemoglobin. Their blood may contain some sickle cells, but they generally don't experience symptoms. However, they are carriers of the disease, which means they can pass the defective gene on to their children.
With each pregnancy, two people with sickle cell traits have:
Jun. 11, 2014
- A 25 percent chance of having an unaffected child with normal hemoglobin
- A 50 percent chance of having a child who also is a carrier
- A 25 percent chance of having a child with sickle cell anemia
- McCavit TL. Sickle cell disease. Pediatrics in Review 2012;33;195.
- Sickle cell anemia. National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/sca/. Accessed Nov. 6, 2013.
- Vichinsky EP. Overview of the clinical manifestations of sickle cell disease. http://www.uptodate.com/home. Accessed Nov. 6, 2013.
- Vichinsky EP, et al. Diagnosis of sickle cell disorders. http://www.uptodate.com/home. Accessed Nov. 6, 2013.
- Steinberg MH. In the clinic. Sickle cell disease. Annals of Internal Medicine. 2011;155:ITC3-1.
- Olowoyeye A, et al. Gene therapy for sickle cell disease. Cochrane Database Systematic Reviews. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007652.pub3/abstract. Accessed Nov. 6, 2013.
- Dong A, et al. Gene therapy for hemoglobinopathies: Progress and challenges. Translational Research. 2013;161:293.
- Sun K, et al. New insights into sickle cell disease: A disease of hypoxia. Current Opinion in Hematology. 2013;20:215.
- Gladwin MT, et al. Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: A randomized controlled trial. JAMA. 2011;305:893.
- Adam SS, et al. Potential role for statins in sickle cell disease. Pediatric Blood Cancer. 2013;60:550.
You Are ... The Campaign for Mayo Clinic
Mayo Clinic is a not-for-profit organization. Make a difference today.